Phendimetrazine Tartrate Capsule, Extended Release
Product Images NDC 72989-409

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Phendimetrazine Tartrate (NDC 72989-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acertis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

The text is indicating the molecular formula of a compound which is C12H7NO.C4HeOg. The text also includes some structural formulas for different molecules. The molecular weight of the compound is given as 34136.*

FDA Label Image

Body Mass Index Table (Image 02)

The text is a table providing the Body Mass Index (BMI) values for different heights and weights. The available heights are 50", 53", 56", 59", 60", 63". The available weights range from 18 pounds to 49 pounds. Therefore, the table helps to identify the BMI based on height and weight.*

FDA Label Image

30-count Bottle Label (Image 03)

This text provides information about the dosage and packaging of Phendimetrazine capsules manufactured by Acertis Pharmaceuticals. Each capsule has 105 mg of phendimetrazine tarirate, and the recommended dose is one capsule per day as specified in the prescribing information. The capsules should be stored in a tight, light-resistant container at a controlled room temperature. The packaging includes a child-resistant closure, and the product is only available by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.